Back to search
FDAFDA · Food and drugs·Recall number Z-1048-2022

BF-MP160F: EVIS EXERA Bronchofibervideoscope

Published May 18, 2022 · Recall initiated: March 8, 2022

Summary

FDA records medical device Class II recall Z-1048-2022, published May 18, 2022 and initiated March 8, 2022. Recalling firm: Olympus Corporation of the Americas; Status: Ongoing; Reported quantity: 292 units; Lot: All serial numbers. UDI: 04953170289064. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Bronchofiberscope Updated instructions on the use of certain chemicals to be used for reprocessing, conditions for ETO gas sterilization, rinsing steps after high-level disinfection, and a recommendation on using sterilization

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Olympus Corporation of the Americas
Distributor
US Nationwide distribution.
Lot
All serial numbers. UDI: 04953170289064
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was BF-MP160F: EVIS EXERA Bronchofibervideoscope recalled?

Yes. FDA published recall Z-1048-2022 on May 18, 2022. Reported hazard: Bronchofiberscope Updated instructions on the use of certain chemicals to be used for reprocessing, conditions for ETO gas sterilization, rinsing steps after high-level disinfection, and a recommendation on using sterilization

What should I do if I have this product?

Voluntary: Firm initiated · Letter